{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:58:02Z","timestamp":1793321882779,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001981","name":"ME Research UK","doi-asserted-by":"publisher","award":["PhD-level research funding"],"award-info":[{"award-number":["PhD-level research funding"]}],"id":[{"id":"10.13039\/501100001981","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute for Health and Care Research (NIHR) and Medical Research Council","award":["MC_PC_20005"],"award-info":[{"award-number":["MC_PC_20005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People with Myalgic Encephalomyelitis (ME\/CFS; sometimes referred to as chronic fatigue syndrome) experience poor health-related quality of life and only rarely recover. ME\/CFS has no curative treatment, and no single diagnostic test. Public health and policy decisions relevant to ME\/CFS require knowledge of its prevalence and barriers to diagnosis. However, people with ME\/CFS report lengthy diagnostic delays and prevalence estimates vary greatly due to uneven diagnosis and misdiagnosis. Factors that influence diagnosis could be revealed by stratifying a single population by gender, age and ethnicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Hospital Episode Statistics data, routinely collected by the NHS in England, was downloaded from the Feasibility Self-Service of NHS DigiTrials. This was used to stratify individuals with the ICD-10 code that best reflects ME\/CFS symptoms (G93.3) according to age, self-reported gender and ethnicity, General Practice and NHS England Integrated Care Board (ICB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In all, 100,055 people in England had been diagnosed with ME\/CFS (ICD-10:G93.3) between April 1 1989 and October 7 2023, 0.16% of all registered patients. Of these, 79,445 were females and 20,590 males, a female-to-male ratio of 3.88:1. Female relative to male prevalence peaked at about 6-to-1 in individuals\u2019 fourth and fifth decades of life. Prevalence varied widely across the 42 ICBs: 0.086%-0.82% for females and 0.024%-0.21% for males. White individuals were approximately fivefold more likely to be diagnosed with ME\/CFS than others; Black, Asian or Chinese ethnicities are associated with particularly low rates of ME\/CFS diagnoses. This ethnicity bias is stronger than for other common diseases. Among active English GP practices, 176 (3%) had no registered ME\/CFS patients. Eight ICBs (19%) each contained fewer than 8 other-than-white individuals with a G93.3 code despite their registers containing a total of 293,770 other-than-white patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Other-than-white ethnic groups, older females (&gt;\u200960y), older males (&gt;\u200980y), and people living in areas of multiple deprivation are disproportionately undiagnosed with ME\/CFS. Lifetime prevalence of ME\/CFS for English females and males may be as high as 0.92% and 0.25%, respectively, or approximately 404,000 UK individuals overall (0.6%). This improved estimate of ME\/CFS prevalence allows more accurate assessment of the socioeconomic and disease burden imposed by ME\/CFS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-025-22603-9","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T19:02:20Z","timestamp":1745262140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Unequal access to diagnosis of myalgic encephalomyelitis in England"],"prefix":"10.1186","volume":"25","author":[{"given":"Gemma Louise","family":"Samms","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P.","family":"Ponting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"22603_CR1","unstructured":"Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome; Board on the Health of Select Populations; Institute of Medicine. Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Redefining an Illness. 2015."},{"key":"22603_CR2","doi-asserted-by":"publisher","first-page":"e0132421","DOI":"10.1371\/journal.pone.0132421","volume":"10","author":"M Falk Hvidberg","year":"2015","unstructured":"Falk Hvidberg M, Brinth LS, Olesen AV, Petersen KD, Ehlers L. The health-related quality of life for patients with Myalgic Encephalomyelitis \/ Chronic Fatigue Syndrome (ME\/CFS). PLoS ONE. 2015;10:e0132421.","journal-title":"PLoS ONE"},{"key":"22603_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/occmed\/kqi013","volume":"55","author":"R Cairns","year":"2005","unstructured":"Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond). 2005;55:20\u201331.","journal-title":"Occup Med (Lond)"},{"key":"22603_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fped.2018.00412","volume":"6","author":"AR Valdez","year":"2018","unstructured":"Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, et al. Estimating prevalence, demographics, and costs of ME\/CFS using large scale medical claims data and machine learning. Front Pediatr. 2018;6:412.","journal-title":"Front Pediatr"},{"key":"22603_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1741-7015-9-91","volume":"9","author":"LC Nacul","year":"2011","unstructured":"Nacul LC, Lacerda EM, Pheby D, Campion P, Molokhia M, Fayyaz S, et al. Prevalence of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med. 2011;9:91.","journal-title":"BMC Med"},{"key":"22603_CR6","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1001\/archinte.163.13.1530","volume":"163","author":"M Reyes","year":"2003","unstructured":"Reyes M, Nisenbaum R, Hoaglin DC, Unger ER, Emmons C, Randall B, et al. Prevalence and incidence of chronic fatigue syndrome in Wichita. Kansas Arch Intern Med. 2003;163:1530\u20136.","journal-title":"Kansas Arch Intern Med"},{"key":"22603_CR7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1001\/archinte.159.18.2129","volume":"159","author":"LA Jason","year":"1999","unstructured":"Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, et al. A community-based study of chronic fatigue syndrome. JAMA Intern Med. 1999;159:2129\u201337.","journal-title":"JAMA Intern Med"},{"key":"22603_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-020-02269-0","volume":"18","author":"E-J Lim","year":"2020","unstructured":"Lim E-J, Ahn Y-C, Jang E-S, Lee S-W, Lee S-H, Son C-G. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME). J Transl Med. 2020;18:100.","journal-title":"J Transl Med"},{"key":"22603_CR9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","volume":"121","author":"K Fukuda","year":"1994","unstructured":"Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953\u20139.","journal-title":"Ann Intern Med"},{"key":"22603_CR10","doi-asserted-by":"crossref","unstructured":"Vahratian A, Lin J-MS, Bertolli J, Unger ER. Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome in Adults: United States, 2021\u20132022. NCHS Data Brief No. 488. 2023. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db488.htm. Accessed 31 Jan 2024.","DOI":"10.15620\/cdc:134504"},{"key":"22603_CR11","unstructured":"National Institute for Health and Care Excellence. Myalgic encephalomyelitis (or encephalopathy) \/ chronic fatigue syndrome: diagnosis and management. 2021."},{"key":"22603_CR12","doi-asserted-by":"crossref","unstructured":"Arron HE, Marsh BD, Kell DB, Khan MA, Jaeger BR, Pretorius E. Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: the biology of a neglected disease. Front Immunol. 2024;15:1386607.","DOI":"10.3389\/fimmu.2024.1386607"},{"key":"22603_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1258\/shorts.2011.011127","volume":"3","author":"A Devasahayam","year":"2012","unstructured":"Devasahayam A, Lawn T, Murphy M, White PD. Alternative diagnoses to chronic fatigue syndrome in referrals to a specialist service: service evaluation survey. JRSM Short Rep. 2012;3:4.","journal-title":"JRSM Short Rep"},{"key":"22603_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4997\/JRCPE.2010.404","volume":"40","author":"JL Newton","year":"2010","unstructured":"Newton JL, Mabillard H, Scott A, Hoad A, Spickett G. The newcastle NHS Chronic fatigue syndrome service: not all fatigue is the same. J R Coll Physicians Edinb. 2010;40:304\u20137.","journal-title":"J R Coll Physicians Edinb"},{"key":"22603_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3310\/nihropenres.13421.2","volume":"3","author":"AD Bretherick","year":"2023","unstructured":"Bretherick AD, McGrath SJ, Devereux-Cooke A, Leary S, Northwood E, Redshaw A, et al. Typing myalgic encephalomyelitis by infection at onset: a DecodeME study. NIHR Open Res. 2023;3:20.","journal-title":"NIHR Open Res"},{"key":"22603_CR16","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/ije\/dyp147","volume":"38","author":"S Dinos","year":"2009","unstructured":"Dinos S, Khoshaba B, Ashby D, White PD, Nazroo J, Wessely S, et al. A systematic review of chronic fatigue, its syndromes and ethnicity: prevalence, severity, co-morbidity and coping. Int J Epidemiol. 2009;38:1554\u201370.","journal-title":"Int J Epidemiol"},{"key":"22603_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10566-019-09543-3","volume":"49","author":"LA Jason","year":"2020","unstructured":"Jason LA, Katz BZ, Sunnquist M, Torres C, Cotler J, Bhatia S. The prevalence of pediatric myalgic encephalomyelitis\/chronic fatigue syndrome in a community-based sample. Child Youth Care Forum. 2020;49:563\u201379.","journal-title":"Child Youth Care Forum"},{"key":"22603_CR18","unstructured":"NHS DigiTrials. 2024. https:\/\/digital.nhs.uk\/services\/nhs-digitrials. Accessed 31 Jan 2024."},{"key":"22603_CR19","unstructured":"Hospital Episode Statistics (HES). 2023. https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/hospital-episode-statistics. Accessed 31 Jan 2024."},{"key":"22603_CR20","first-page":"167","volume":"12","author":"IJ Bakken","year":"2014","unstructured":"Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, et al. Two age peaks in the incidence of chronic fatigue syndrome\/myalgic encephalomyelitis: a population-based registry study from Norway 2008\u20132012. BMC Med. 2014;12:167.","journal-title":"BMC Med"},{"key":"22603_CR21","unstructured":"Writing about ethnicity. 2021. https:\/\/www.ethnicity-facts-figures.service.gov.uk\/style-guide\/writing-about-ethnicity\/. Accessed 31 Jan 2024."},{"key":"22603_CR22","unstructured":"English indices of deprivation 2019. 2019. https:\/\/www.gov.uk\/government\/statistics\/english-indices-of-deprivation-2019. Accessed 31 Jan 2024."},{"key":"22603_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/0141076817702530","volume":"110","author":"SM Collin","year":"2017","unstructured":"Collin SM, Bakken IJ, Nazareth I, Crawley E, White PD. Trends in the incidence of chronic fatigue syndrome and fibromyalgia in the UK, 2001\u20132013: a clinical practice research datalink study. J R Soc Med. 2017;110:231\u201344.","journal-title":"J R Soc Med"},{"key":"22603_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/jpc.12425","volume":"49","author":"S Knight","year":"2013","unstructured":"Knight S, Harvey A, Lubitz L, Rowe K, Reveley C, Veit F, et al. Paediatric chronic fatigue syndrome: complex presentations and protracted time to diagnosis. J Paediatr Child Health. 2013;49:919\u201324.","journal-title":"J Paediatr Child Health"},{"key":"22603_CR25","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1186\/s12889-022-13929-9","volume":"22","author":"N Orji","year":"2022","unstructured":"Orji N, Campbell JA, Wills K, Hensher M, Palmer AJ, Rogerson M, et al. Prevalence of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) in Australian primary care patients: only part of the story? BMC Public Health. 2022;22:1516.","journal-title":"BMC Public Health"},{"key":"22603_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1756-0500-4-139","volume":"4","author":"D Pheby","year":"2011","unstructured":"Pheby D, Lacerda E, Nacul L, de Drachler ML, Campion P, Howe A, et al. A disease register for report of a pilot study. BMC Res Notes. 2011;4:139.","journal-title":"BMC Res Notes"},{"key":"22603_CR27","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(15)01223-4","volume":"387","author":"E Roberts","year":"2016","unstructured":"Roberts E, Wessely S, Chalder T, Chang C-K, Hotopf M. Mortality of people with chronic fatigue syndrome: a retrospective cohort study in England and Wales from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Clinical Record Interactive Search (CRIS) Register. Lancet. 2016;387:1638\u201343.","journal-title":"Lancet"},{"key":"22603_CR28","unstructured":"NHS Digital. Summary Report - outpatient appointments by gender. Summary - outpatient attendances by age and gender (incl. maternity specific attendances), 2019\u201320. 2020. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/hospital-outpatient-activity\/2019-20\/summary-report---gender. Accessed 4 Feb 2024."},{"key":"22603_CR29","unstructured":"Mortality from leading causes of death by ethnic group, England and Wales: 2012 to 2019. 2021. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/articles\/mortalityfromleadingcausesofdeathbyethnicgroupenglandandwales\/2012to2019. Accessed 31 Jan 2024."},{"key":"22603_CR30","unstructured":"Birney E, Inouye M, Raff J, Rutherford A, Scally A. The language of race, ethnicity, and ancestry in human genetic research. 2021."},{"issue":"63","key":"22603_CR31","first-page":"1022","volume":"2009","author":"JY Nazroo","year":"1978","unstructured":"Nazroo JY, Falaschetti E, Pierce M, Primatesta P. Ethnic inequalities in access to and outcomes of healthcare: analysis of the health survey for England. J Epidemiol Community Health. 1978;2009(63):1022\u20137.","journal-title":"J Epidemiol Community Health"},{"key":"22603_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2307\/j.ctv14t47tm.10","volume-title":"Ethnicity, Race and Inequality in the UK","author":"K Chouhan","year":"2020","unstructured":"Chouhan K, Nazroo J. Health inequalities. In: Byrne B, Alexander C, Khan O, Nazroo J, Shankley W, editors. Ethnicity, Race and Inequality in the UK. Bristol: Bristol University Press; 2020. p. 73\u201392."},{"key":"22603_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1017\/S1463423613000145","volume":"15","author":"K Bayliss","year":"2014","unstructured":"Bayliss K, Riste L, Fisher L, Wearden A, Peters S, Lovell K, et al. Diagnosis and management of chronic fatigue syndrome\/myalgic encephalitis in black and minority ethnic people: a qualitative study. Prim Health Care Res Dev. 2014;15:143\u201355.","journal-title":"Prim Health Care Res Dev"},{"key":"22603_CR34","unstructured":"Diagnosis of ME\/CFS. The importance of having an early and accurate diagnosis. 2022.\u00a0\u00a0https:\/\/meassociation.org.uk\/wp-content\/uploads\/2025\/02\/Diagnosis-of-ME-CFS-The-importance-of-an-early-and-accurate-diagnosis-APRIL-2022.pdf."},{"key":"22603_CR35","doi-asserted-by":"publisher","first-page":"106297","DOI":"10.1016\/j.jinf.2024.106297","volume":"89","author":"A Dehlia","year":"2024","unstructured":"Dehlia A, Guthridge MA. The persistence of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) after SARS-CoV-2 infection: a systematic review and meta-analysis. J Infect. 2024;89:106297.","journal-title":"J Infect"},{"key":"22603_CR36","doi-asserted-by":"publisher","first-page":"e001417","DOI":"10.1136\/bmjopen-2012-001417","volume":"2","author":"SM Collin","year":"2012","unstructured":"Collin SM, Sterne JAC, Hollingworth W, May MT, Crawley E. Equity of access to specialist chronic fatigue syndrome (CFS\/ME) services in England (2008\u20132010): a national survey and cross-sectional study. BMJ Open. 2012;2:e001417.","journal-title":"BMJ Open"},{"key":"22603_CR37","unstructured":"Samms GL, Ponting CP. Defining a High-Quality Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome cohort in UK Biobank. 2025."},{"key":"22603_CR38","unstructured":"Population estimates for the UK, England, Wales, Scotland, and Northern Ireland: mid-2023. 2024. https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/populationandmigration\/populationestimates\/bulletins\/annualmidyearpopulationestimates\/mid2023. Accessed 31 Jan 2024."},{"key":"22603_CR39","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3390\/medicina57060542","volume":"57","author":"N Muirhead","year":"2021","unstructured":"Muirhead N, Muirhead J, Lavery G, Marsh B. Medical school education on myalgic encephalomyelitis. Medicina (Kaunas). 2021;57:542.","journal-title":"Medicina (Kaunas)"},{"key":"22603_CR40","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1177\/13591053211027631","volume":"27","author":"L Froehlich","year":"2022","unstructured":"Froehlich L, Hattesohl DB, Cotler J, Jason LA, Scheibenbogen C, Behrends U. Causal attributions and perceived stigma for myalgic encephalomyelitis\/chronic fatigue syndrome. J Health Psychol. 2022;27:2291\u2013304.","journal-title":"J Health Psychol"},{"key":"22603_CR41","first-page":"148","volume":"12","author":"P Asbring","year":"2002","unstructured":"Asbring P, N\u00e4rv\u00e4nen A-L. Women\u2019s experiences of stigma in relation to chronic fatigue syndrome and fibromyalgia. Qual Health Res. 2002;12:148\u201360.","journal-title":"Qual Health Res"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22603-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22603-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22603-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T19:02:29Z","timestamp":1745262149000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22603-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22603"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22603-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.31.24302070","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NHS data is copyright \u00a9 2022, NHS England, re-used with the permission of NHS England. All rights reserved. Access to this data was provided by NHS DigiTrials and the Feasibility Self-Service whose legal basis for collecting the data is the Public task and Health and Social Care Act \u2013 General powers. The legal basis for NHS DigiTrials and the Feasibility Self-Service\u2019s processing of personal information is described here:\n                      \n                      . Consent is not the basis for data processing.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1417"}}